⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL10613718 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL11277510 | 0.96 | — | — | |
| SCHEMBL587920 | 0.78 | — | — | |
| SCHEMBL13430331 | 0.78 | — | — | |
| SCHEMBL8627727 | 0.78 | — | — | |
| SCHEMBL3079429 | 0.75 | — | — | |
| SCHEMBL11869832 | 0.75 | — | — | |
| SCHEMBL2180988 | 0.75 | — | — | |
| SCHEMBL1358816 | 0.75 | — | — | |
| Ammonia Solution, Strong SCHEMBL11435772 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2300 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12571004-B2 | Exosomal loading using hydrophobically modified oligonucleotides | UNIVERSITY OF MASSACHUSETTS (US) | 2026-03-10 | — | — | US | claimed |
| US-20260035703-A1 | Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2C Using Exon Skipping | UNIV CHICAGO (US) | 2026-02-05 | — | — | US | claimed |
| US-20260009033-A1 | ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHOD OF TREATING DYSTROPHIES | UNIV CHICAGO (US) | 2026-01-08 | — | — | US | claimed |
| EP-4665850-A2 | OLIGONUCLEOTIDES FOR MODULATING APOLIPOPROTEIN E (APOE) EXPRESSION AND METHODS OF USE THEREOF | SciNeuro Therapeutics Inc. (US) | 2025-12-24 | — | — | EP | claimed |
| US-20250368999-A1 | SOLUBLE INTERLEUKIN-7 RECEPTOR (SIL7R) MODULATING THERAPY TO TREAT CANCER | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-12-04 | — | — | US | claimed |
| US-12359204-B2 | Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune diseases and cancer | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-07-15 | — | — | US | claimed |
| US-20250179495-A1 | ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHOD OF TREATING DYSTROPHIES | UNIV CHICAGO (US) | 2025-06-05 | — | — | US | claimed |
| US-20250154504-A1 | GUIDE OLIGONUCLEOTIDES FOR NUCLEIC ACID EDITING IN THE TREATMENT OF HYPERCHOLESTEROLEMIA | PROQR THERAPEUTICS II B.V. (NL) | 2025-05-15 | — | — | US | claimed |
| WO-2025096511-A1 | CLEC2D TARGETING CONJUGATES AND RELATED METHODS | IMMUNITAS THERAPEUTICS, INC. (US) | 2025-05-08 | — | — | WO | claimed |
| CN-113785061-B | Restoration of CFTR function by splicing regulation | 耶路撒冷希伯来大学伊森姆研究发展有限公司 | 2025-04-29 | — | — | CN | claimed |
| WO-2004016805-A9 | IMMUNOSTIMULATORY NUCLEIC ACIDS | COLEY PHARM GROUP INC (US) | 2004-08-19 | — | — | WO | claimed |
| WO-2004016805-A2 | IMMUNOSTIMULATORY NUCLEIC ACIDS | COLEY PHARMACEUTICAL GROUP, INC. (US) | 2004-02-26 | — | — | WO | claimed |
| US-20030104464-A1 | Method for the high-parallel analysis of polymorphisms | EPIGENOMICS AG (DE) | 2003-06-05 | — | — | US | claimed |
| CN-1315133-A | Pesticide composition composed of pesticide organophosphorus compound and pesticide compound containing pyrazolyl | AGREVO UK LTD (FR) | 2001-10-03 | — | — | CN | claimed |
| CN-1215994-A | Rnase L activators and antisense oligonucleotides effective to treat RSV infections | NAT INST HEALTH (US) | 1999-05-05 | — | — | CN | claimed |
| EP-0695170-A4 | LONG-ACTING TREATMENT BY SLOW-RELEASE DELIVERY OF ANTISENSE OLIGODEOXYRIBONUCLEOTIDES FROM BIODEGRADABLE MICROPARTICLES | MEDISORB TECHNOLOGIES INTERNAT (US) | 1998-08-19 | — | — | EP | claimed |
| WO-1998005675-A2 | RADIOLABELED O-METHYL PHOSPHOTRIESTER AND O-METHYL PHOSPHOROTHIOATE INTERNUCLEOSIDE LINKAGES AND OLIGONUCLEOTIDES CONTAINING THE SAME | HYBRIDON, INC. (US) | 1998-02-12 | — | — | WO | claimed |
| WO-1996039414-A1 | NOVEL BASE PROTECTING GROUPS FOR OLIGONUCLEOTIDE SYNTHESIS | HYBRIDON, INC. (US) | 1996-12-12 | — | — | WO | claimed |
| EP-0695170-A1 | LONG-ACTING TREATMENT BY SLOW-RELEASE DELIVERY OF ANTISENSE OLIGODEOXYRIBONUCLEOTIDES FROM BIODEGRADABLE MICROPARTICLES | MEDISORB TECHNOLOGIES INTERNATIONAL L.P. (US) | 1996-02-07 | — | — | EP | claimed |
| WO-1994023699-A1 | LONG-ACTING TREATMENT BY SLOW-RELEASE DELIVERY OF ANTISENSE OLIGODEOXYRIBONUCLEOTIDES FROM BIODEGRADABLE MICROPARTICLES | MEDISORB TECHNOLOGIES INTERNATIONAL L.P. (US) | 1994-10-27 | — | — | WO | claimed |